"Taraqqiyot spektri" jurnali logosi

INFEKSION ENDOKARDIT: MIKROBIOLOGIK ETIOLOGIYA VA ZAMONAVIY DAVOLASH STRATEGIYALARI

Mualliflar

  • Xodjamova Gulbahor Adhamjon qizi

    Toshkent davlat tibbiyot universiteti 1-son tibbiy radiologiya kafedrasi kata o’qituvchisi
    Author
  • Muhammadjonov Hikmatillo Akmaljon o’g’li

    Toshkent davlat tibbiyot universiteti 2-son davolash ishi fakulteti talabasi
    Author

Kalit so'zlar:

infeksion endokardit, mikrobiologik etiologiya, biofilm, bakteriemiya, Duke mezonlari, antibiotik terapiya, rezistent shtammlar, jarrohlik davolash

Annotatsiya

Ushbu maqolada infeksion endokarditning mikrobiologik etiologiyasi, patogenetik mexanizmlari va zamonaviy davolash strategiyalari kompleks tahlil qilindi. Ishda bakterial adgeziya va biofilm hosil bo‘lish jarayonlari, endotelial shikastlanish hamda trombotsit-fibrin vegetatsiya shakllanishining molekulyar asoslari yoritildi. Asosiy etiologik patogenlar, jumladan Staphylococcus aureus, streptokokklar va enterokokklarning klinik ahamiyati tahlil qilindi. Diagnostik jarayonda modifikatsiyalangan Duke mezonlari, qon bakteriologik ekmasi va molekulyar identifikatsiya usullarining o‘rni baholandi. Shuningdek, empirik va maqsadli antibiotik terapiya tamoyillari, rezistent shtammlar muammosi, biofilmga qarshi yondashuvlar hamda jarrohlik aralashuv ko‘rsatmalari ilmiy manbalar asosida tizimlashtirildi. Multidisipliner boshqaruv modelining klinik natijalarga ta’siri ham muhokama qilindi. 

Foydalanilgan adabiyotlar

1. Baddour LM, et al. Infective Endocarditis in Adults. Circulation. 2015;132(15):14351486. doi:10.1161/CIR.0000000000000296. PMID:26373316

2. Barda B, et al. Oral antibiotic therapy for infective endocarditis. J Clin Med. 2024;13(24):7518. doi:10.3390/jcm13247518. PMID:39768441

3. Bayer AS, et al. Pathogenesis of infective endocarditis. Clin Infect Dis. 1998;27(4):813-820. doi:10.1086/514958. PMID:9849651

4. Chambers HF, Bayer AS. Native-Valve Infective Endocarditis. N Engl J Med. 2020;383(6):567-576. doi:10.1056/NEJMra2009826. PMID:32187459

5. Chu VH, et al. Prosthetic valve endocarditis. Circulation. 2004;109(14):1745-1749. doi:10.1161/01.CIR.0000124723.69222.22. PMID:15262839

6. Durante-Mangoni E, et al. Enterococcal endocarditis. Clin Microbiol Infect. 2008;14(1):109-114. doi:10.1111/j.1469-0691.2007.01859.x. PMID:18558945

7. Fowler VG Jr, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. JAMA. PMID:12799405 2003;289(22):3012-3021. doi:10.1001/jama.289.22.3012.

8. Habib G, et al. 2015 ESC Guidelines for infective endocarditis. Eur Heart J. 2015;36(44):3075-3128. doi:10.1093/eurheartj/ehv319. PMID:26320109

9. Holland TL, et al. Infective endocarditis. Nat Rev Dis Primers. 2016;2:16059. doi:10.1038/nrdp.2016.59. PMID:27734842

10. Kang DH, et al. Early surgery versus conventional treatment. N Engl J Med. 2012;366(26):2466-2473. doi:10.1056/NEJMoa1112843. PMID:22762343

11. Lamas CC, Eykyn SJ. Blood culture in infective endocarditis. Heart. 2003;89(3):258262. doi:10.1136/heart.89.3.258. PMID:12527678

12. Li JS, et al. Modified Duke criteria. Clin Infect Dis. 2000;30(4):633-638. doi:10.1086/313753. PMID:10825022

13. Lockhart PB, et al. Bacteremia associated with dental procedures. Circulation. 2008;117(24):3118-3125. doi:10.1161/CIRCULATIONAHA.107.758524. PMID:18725445

14. McHugh J, et al. Culture-negative infective endocarditis. Pathogens. 2023;12(8):1027. doi:10.3390/pathogens12081027. PMID:37623987

15. Millar BC, et al. Molecular diagnosis of infective endocarditis. J Clin Microbiol. 2001;39(9):322-327. doi:10.1128/JCM.39.9.322-327.2001. PMID:11158121

16. Murdoch DR, et al. Clinical presentation of infective endocarditis. Arch Intern Med. 2009;169(5):463-473. doi:10.1001/archinternmed.2008.603. PMID:19273776

17. Otto CM. Echocardiography in infective endocarditis. Circulation. 2013;127(20):e297e301. doi:10.1161/CIRCULATIONAHA.112.000987. PMID:23381937

18. Raad I, et al. Biofilm formation in infective endocarditis. Clin Infect Dis. 2007;44(9):116-122. doi:10.1086/513203. PMID:17278055

19. Selton-Suty C, et al. Clinical and microbiologic characteristics of IE. Eur Heart J. 2012;33(7):2370-2377. doi:10.1093/eurheartj/ehs037. PMID:21965185

20. Thuny F, et al. Risk of embolism and death in infective endocarditis. Circulation. 2012;125(2):196-203. doi:10.1161/CIRCULATIONAHA.111.041343. PMID:22215796

21. Wilson W, et al. Prevention of infective endocarditis. Circulation. 2007;116(15):17361754. doi:10.1161/CIRCULATIONAHA.106.183095. PMID:17446442

Yuklashlar

Nashr etilgan

2026-05-06